Press release
Biliary Tract Cancers Pipeline Outlook Report 2024 | Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd
DelveInsight's, "Biliary Tract Cancers Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Biliary Tract Cancers pipeline landscape. It covers the Biliary Tract Cancers pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Biliary Tract Cancers pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Key Takeaways from the Biliary Tract Cancers Pipeline Report
• DelveInsight's Biliary Tract Cancers pipeline report depicts a robust space with 80+ active players working to develop 80+ pipeline therapies for Biliary Tract Cancers treatment.
• The leading companies working in the Biliary Tract Cancers market include Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee's Pharmaceutical Limited, Hoffmann-La Roche, Shanghai Miracogen Inc., Zymeworks Inc., Bristol-Myers Squibb, Eli Lilly and Company, Ipsen, Threshold Pharmaceuticals, Leap Therapeutics, Hutchison Medipharma Limited, Array BioPharma, Redx Pharma Plc, Compass Therapeutics, Lee's Pharmaceutical Limited, and others.
• Promising Biliary Tract Cancers Pipeline Therapies in the various stages of development include M7824, SMT-NK inj.+Pembrolizumab, Durvalumab, mFOLFOX, ZKAB001 5mg/kg, Capecitabine, RC48-ADC, Atezolizumab, Bevacizumab, Lenvatinib, MRG003, Gemcitabine, Cisplatin, and others.
• March 2024: AstraZeneca announced a study of Phase 3 clinical trials for Gemcitabine monotherapy. A study to assess the safety and efficacy of durvalumab in combination with gemcitabine-based chemotherapy regimens in participants with aBTC.
• March 2024: InnovPharmax Inc. announced a study of Phase 3 clinical triails for D07001-softgel capsules + Xeloda (or TS-1) and mFOLFOX. In phase IIa, a modified 3+3 dose-finding design trial will be conducted to identify the selected dose of the combination of D07001-softgel capsules plus Xeloda (or TS-1). After the dose-finding stage will be completed, a phase IIb/III adaptive design, open label, multicenter, active controlled, parallel-group trial will be implemented and incorporated into a dose-expansion stage to evaluate the efficacy and safety of D07001-softgel capsules plus Xeloda.
Request a sample and discover the recent advances in Biliary Tract Cancers Treatment Drugs @ Biliary Tract Cancers Pipeline Report- https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Biliary Tract Cancers pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Biliary Tract Cancers drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the Biliary Tract Cancers clinical trial landscape.
Biliary Tract Cancers Overview
Biliary tract cancer is a cancer that forms in the cells of the bile ducts, gallbladder or ampulla of Vater. Cancer of the bile ducts is called cholangiocarcinoma and is classified depending on which part of the bile duct the cancer develops into intrahepatic (affects bile ducts within the liver), hilar (occurs at the junction of the left and right hepatic ducts) and extrahepatic (affects the common bile duct outside the liver) sharing different genetic, risk factors and clinical presentation.
Find out more about Biliary Tract Cancers Treatment Drugs @ Drugs for Biliary Tract Cancers Treatment- https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Biliary Tract Cancers Emerging Drugs Profile
• MRG 002: Miracogen
• Disitamab vedotin: Yantai Rongchang Pharmaceutical
• Envafolimab: Alphamab Oncology
• DKN-01: Leap Therapeutics
Biliary Tract Cancers Pipeline Therapeutics Assessment
The Biliary Tract Cancers pipeline report proffers an integral view of the Biliary Tract Cancers emerging novel therapies segmented by stage, product type, molecule type, mechanism of action, and route of administration.
DelveInsight's Biliary Tract Cancers Pipeline report covers around 80+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Biliary Tract Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular
Biliary Tract Cancers Pipeline Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide
Learn more about the emerging Biliary Tract Cancers Pipeline Therapies @ Biliary Tract Cancers Clinical Trials Assessment- https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Biliary Tract Cancers Pipeline Report
• Coverage- Global
• Biliary Tract Cancers Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Biliary Tract Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Biliary Tract Cancers Companies- Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee's Pharmaceutical Limited, Hoffmann-La Roche, Shanghai Miracogen Inc., Zymeworks Inc., Bristol-Myers Squibb, Eli Lilly and Company, Ipsen, Threshold Pharmaceuticals, Leap Therapeutics, Hutchison Medipharma Limited, Array BioPharma, Redx Pharma Plc, Compass Therapeutics, Lee's Pharmaceutical Limited, and others.
• Biliary Tract Cancers Pipeline Therapies- M7824, SMT-NK inj.+Pembrolizumab, Durvalumab, mFOLFOX, ZKAB001 5mg/kg, Capecitabine, RC48-ADC, Atezolizumab, Bevacizumab, Lenvatinib, MRG003, Gemcitabine, Cisplatin, and others.
Dive deep into rich insights for new drugs for Biliary Tract Cancers Treatment, Visit @ Biliary Tract Cancers Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Biliary Tract Cancer: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Biliary Tract Cancer- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Envafolimab: Alphamab Oncology
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II/III)
11. SMT-NK: SMT bio Co., Ltd.
12. Drug profiles in the detailed report…..
13. Mid Stage Products (Phase II)
14. HA121-28: CSPC ZhongQi Pharmaceutical Technology
15. Drug profiles in the detailed report…..
16. Early Stage Products (Phase I)
17. ZKAB001: Lee's Pharmaceutical Limited
18. Drug profiles in the detailed report…..
19. Preclinical and Discovery Stage Products
20. Drug name: Company name
21. Drug profiles in the detailed report…..
22. Inactive Products
23. Biliary Tract Cancer Key Companies
24. Biliary Tract Cancer Key Products
25. Biliary Tract Cancer- Unmet Needs
26. Biliary Tract Cancer- Market Drivers and Barriers
27. Biliary Tract Cancer- Future Perspectives and Conclusion
28. Biliary Tract Cancer Analyst Views
29. Biliary Tract Cancer Key Companies
30. Appendix
For further information on the Biliary Tract Cancers Pipeline therapeutics, reach out to Biliary Tract Cancers Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Links-
https://germanydennydones.bloggip.com/profile
https://germanydennydones.creacionblog.com/profile
https://germanydennydones.dm-blog.com/profile
https://germanydennydones.tusblogos.com/profile
https://germanydennydones.spintheblog.com/profile
https://germanydennydones.dailyblogzz.com/profile
https://germanydennydones.bloginder.com/profile
https://germanydennydones.blogvivi.com/profile
https://germanydennydones.bleepblogs.com/profile
https://germanydennydones.get-blogging.com/profile
https://germanydennydones.targetblogs.com/profile
https://germanydennydones.newsbloger.com/profile
https://germanydennydones.blogdal.com/profile
https://germanydennydones.ja-blog.com/profile
https://germanydennydones.blogscribble.com/profile
https://germanydennydones.madmouseblog.com/profile
https://germanydennydones.activoblog.com/profile
https://germanydennydones.blog-ezine.com/profile
https://germanydennydones.blogtov.com/profile
https://germanydennydones.digitollblog.com/profile
https://germanydennydones.blazingblog.com/profile
https://germanydennydones.smblogsites.com/profile
https://germanydennydonesc.weblogco.com/profile
https://germanydennydones.blogdeazar.com/profile
https://germanydennydones.eedblog.com/profile
https://germanydennydones.theisblog.com/profile
https://germanydennydones.blog2freedom.com/profile
https://germanydennydones.qodsblog.com/profile
https://germanydennydones.bloggazza.com/profile
https://germanydennydones.bloggactivo.com/profile
https://germanydennydones.bloggadores.com/profile
https://germanydennydones.blogsvirals.com/profile
https://germanydennydones.blog-gold.com/profile
https://germanydennydones.ambien-blog.com/profile
https://germanydennydones.atualblog.com/profile
https://germanydennydones.blog-a-story.com/profile
https://germanydennydones.blogacep.com/profile
https://germanydennydones.blogadvize.com/profile
https://germanydennydones.bloggerbags.com/profile
https://germanydennydones.bloggerswise.com/profile
https://germanydennydones.bloggosite.com/profile
https://germanydennydones.blogoscience.com/profile
https://germanydennydones.blogproducer.com/profile
https://germanydennydones.blogrelation.com/profile
https://germanydennydones.blogrenanda.com/profile
https://germanydennydones.blogsidea.com/profile
https://germanydennydones.blogthisbiz.com/profile
https://germanydennydones.blue-blogs.com/profile
https://germanydennydones.csublogs.com/profile
https://germanydennydones.dailyhitblog.com/profile
https://germanydennydones.develop-blog.com/profile
https://germanydennydones.livebloggs.com/profile
https://germanydennydones.is-blog.com/profile
https://hyperbookmarks.com/story16829911/atopic-dermatitis-market-size
https://hotbookmarkings.com/story16883941/atopic-dermatitis-market-outlook
https://extrabookmarking.com/story16805585/atopic-dermatitis-market-forecast
https://enrollbookmarks.com/story16793892/atopic-dermatitis-market-trends
https://digibookmarks.com/story16832272/atopic-dermatitis-treatment-market
https://bookmarktune.com/story16785555/atopic-dermatitis-market-insights
https://bookmarkpressure.com/story16812823/atopic-dermatitis-market
https://bookmarkjourney.com/story16864476/atopic-dermatitis-market-size
https://bookmarkindexing.com/story16742365/atopic-dermatitis-market-outlook
https://maximusbookmarks.com/story16970425/atopic-dermatitis-market-forecast
https://bookmarkforest.com/story16794298/atopic-dermatitis-drug-market
https://bookmarkchamp.com/story16807071/atopic-dermatitis-drug-market
https://bookmarkingquest.com/story16806001/atopic-dermatitis-drug-market
https://bookmarkingbay.com/story16763993/atopic-dermatitis-drug-market
https://active-bookmarks.com/story16761273/atopic-dermatitis-market-forecast
https://dmozbookmark.com/story16828056/atopic-dermatitis-drug-market
https://bookmarklinx.com/story16889261/atopic-dermatitis-market-outlook
https://bookmarkerz.com/story16762032/atopic-dermatitis-market-size
https://bookmarkahref.com/story16846516/atopic-dermatitis-drug-market
https://top10bookmark.com/story16738693/atopic-dermatitis-market-size
https://tinybookmarks.com/story16871257/atopic-dermatitis-market-outlook
https://thebookmarknight.com/story16844966/atopic-dermatitis-market-trends
https://scrapbookmarket.com/story16804746/atopic-dermatitis-market-share
https://royalbookmarking.com/story16846844/atopic-dermatitis-drug-market
https://nanobookmarking.com/story16794126/atopic-dermatitis-treatment-market-size
https://modernbookmarks.com/story16676860/atopic-dermatitis-treatment-market
https://listingbookmarks.com/story16875255/atopic-dermatitis-market-trends
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/vulvar-cancer-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biliary Tract Cancers Pipeline Outlook Report 2024 | Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd here
News-ID: 3434452 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Biliary
Global Metal Pancreatic Biliary Stent Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Metal Pancreatic Biliary Stent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The metal pancreatic biliary stent market is witnessing consistent growth due to the rising prevalence of…
Major Market Share Shift in Biliary Catheters Industry: Advancements In Biliary …
What Is the Forecasted Market Size and Growth Rate for the Biliary Catheters Market?
The market size for biliary catheters has experienced robust growth in recent years. There is an expected growth from $3.42 billion in 2024 to $3.75 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.7%. Factors like increased occurrences of biliary tract ailments, the popularity of minimally invasive procedures, a growing aging population, more…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Biliary Stents Market - Unleashing Flow: Empowering Biliary Health with Innovati …
Newark, New Castle, USA - new report, titled Biliary Stents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biliary Stents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biliary Stents market. The report offers an overview of the market, which…
High Prevalence of Biliary Diseases Across the Globe is Driving the Biliary Sten …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
Rise in Surgical Procedures of Biliary Diseases is Expected to Boost the Biliary …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…